Abstract

The efficient entry of nanotechnology-based pharmaceuticals into target cells is highly desired to reach high therapeutic efficiency while minimizing the side effects. Despite intensive research, the impact of the surface coating on the mechanism of nanoparticle uptake is not sufficiently understood yet. Herein, we present a mechanistic study of cellular internalization pathways of two magnetic iron oxide nanoparticles (MNPs) differing in surface chemistry into A549 cells. The MNP uptake was investigated in the presence of different inhibitors of endocytosis and monitored by spectroscopic and imaging techniques. The results revealed that the route of MNP entry into cells strongly depends on the surface chemistry of the MNPs. While serum bovine albumin-coated MNPs entered the cells via clathrin-mediated endocytosis (CME), caveolin-mediated endocytosis (CavME) or lipid rafts were preferentially involved in the internalization of polyethylene glycol-coated MNPs. Our data indicate that surface engineering can contribute to an enhanced delivery efficiency of nanoparticles.

Highlights

  • IntroductionMagnetic iron oxide nanoparticles (MNPs) as chemically inert material have been increasingly employed as contrast agents in magnetic resonance imaging (MRI), positron emission tomography (PET), and near-infrared fluorescence (NIRF) imaging [1]

  • Magnetic iron oxide nanoparticles (MNPs) as chemically inert material have been increasingly employed as contrast agents in magnetic resonance imaging (MRI), positron emission tomography (PET), and near-infrared fluorescence (NIRF) imaging [1].The superparamagnetic properties of MNPs make them eligible for the targeted delivery of the drug-loaded particles to the tumor mass via an external magnetic field [2]

  • Initial experiments were focused on the expression of clathrin heavy chain (CLHC), dynamin (Dyn), caveolin-1 (Cav1), and its phosphorylated form in A549 cells

Read more

Summary

Introduction

Magnetic iron oxide nanoparticles (MNPs) as chemically inert material have been increasingly employed as contrast agents in magnetic resonance imaging (MRI), positron emission tomography (PET), and near-infrared fluorescence (NIRF) imaging [1]. The superparamagnetic properties of MNPs make them eligible for the targeted delivery of the drug-loaded particles to the tumor mass via an external magnetic field [2]. MNPs are promising biosensors [3] and antimicrobial tools [4], Beilstein J. They play an important role in the development of multifunctional theranostics to combat cancer [5]. There are physiologically well tolerated as iron is an essential nutrient for almost all life forms [6]. Iron oxide nanoparticles are the only one FDA-approved magnetic nanoparticles for biomedical application (Resovist)

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.